MicrobeWorld App


Microbes After Hours


Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email


Featured Image

Featured Video

Ebola Virus explained


ASM House 200X200

UC study tests vaccine against bacteria

An experimental vaccine could be the newest weapon against a dangerous bacterial infection on the rise in hospitals and nursing homes around the United States.

Doctors at the University of Cincinnati and University Hospital are part of a national clinical trial testing a C. difficile - or C. diff - vaccine.

The experimental vaccine, developed by sanofi pasteurof Swiftwater, Pa., will be administered to at least 10 adults locally who've had a previous C. diff infection to prevent a recurrence, said Bruce Yacyshyn, the gastroenterologist heading up the local branch of the trial. Nationally, organizers hope to recruit 612 adults for the trial.

"C. diff is becoming a major healthcare problem in America, largely due to the use of antibiotics," Yacyshyn said.

C. difficile are bacteria that are naturally present in the digestive tract. But in some people - those with compromised immune systems, or those who've been on antibiotic therapy - they can grow out of control.

Comments (0)

Collections (0)


American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use